aluates Reports

$ 0.0

Global Cancer Targeted Drug Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-24N11456

Global Cancer Targeted Drug Market Research Report 2022

BUY CHAPTERS

Global Cancer Targeted Drug Market Research Report 2025

Code: QYRE-Auto-24N11456

Report

January 2025

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

Eisai Co Ltd

Zelgen

Cipla Ltd

Natco Pharma

Astrazeneca plc

Novartis

Roche

Bristol–Myers Squibb

Pfizer Inc

Beacon Pharma

Jiangxi Shanxiang

Yao Pharma

CSPC

Chiatai Tianqing

Simcere

Cancer Targeted Drug Market Size

The global market for Cancer Targeted Drug was valued at US$ 61670 million in the year 2024 and is projected to reach a revised size of US$ 113940 million by 2031, growing at a CAGR of 9.3% during the forecast period.

Cancer Targeted Drug Market

Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cancer Targeted Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Targeted Drug.

The Cancer Targeted Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Targeted Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Targeted Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Targeted Drug Market Report

Report Metric	Details
Report Name	Cancer Targeted Drug Market
Accounted market size in year	US$ 61670 million
Forecasted market size in 2031	US$ 113940 million
CAGR	9.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Sorafenib Lenvatinib Regorafenib Osimertinib Anlotinib Alectinib Other
Segment by Application	Hospital Retail Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche, Bristol-Myers Squibb, Pfizer, BEACON Pharma, Jiangxi Shanxiang, Yao Pharma, CSPC, CHIATAI Tianqing, Simcere
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Targeted Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cancer Targeted Drug Market growing?

Ans: The Cancer Targeted Drug Market witnessing a CAGR of 9.3% during the forecast period 2025-2031.

What is the Cancer Targeted Drug Market size in 2031?

Ans: The Cancer Targeted Drug Market size in 2031 will be US$ 113940 million.

Who are the main players in the Cancer Targeted Drug Market report?

Ans: The main players in the Cancer Targeted Drug Market are Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche, Bristol-Myers Squibb, Pfizer, BEACON Pharma, Jiangxi Shanxiang, Yao Pharma, CSPC, CHIATAI Tianqing, Simcere

What are the Application segmentation covered in the Cancer Targeted Drug Market report?

Ans: The Applications covered in the Cancer Targeted Drug Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Cancer Targeted Drug Market report?

Ans: The Types covered in the Cancer Targeted Drug Market report are Sorafenib, Lenvatinib, Regorafenib, Osimertinib, Anlotinib, Alectinib, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Targeted Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Sorafenib

1.2.3 Lenvatinib

1.2.4 Regorafenib

1.2.5 Osimertinib

1.2.6 Anlotinib

1.2.7 Alectinib

1.2.8 Other

1.3 Market by Application

1.3.1 Global Cancer Targeted Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Targeted Drug Market Perspective (2020-2031)

2.2 Global Cancer Targeted Drug Growth Trends by Region

2.2.1 Global Cancer Targeted Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cancer Targeted Drug Historic Market Size by Region (2020-2025)

2.2.3 Cancer Targeted Drug Forecasted Market Size by Region (2026-2031)

2.3 Cancer Targeted Drug Market Dynamics

2.3.1 Cancer Targeted Drug Industry Trends

2.3.2 Cancer Targeted Drug Market Drivers

2.3.3 Cancer Targeted Drug Market Challenges

2.3.4 Cancer Targeted Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Targeted Drug Players by Revenue

3.1.1 Global Top Cancer Targeted Drug Players by Revenue (2020-2025)

3.1.2 Global Cancer Targeted Drug Revenue Market Share by Players (2020-2025)

3.2 Global Cancer Targeted Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cancer Targeted Drug Revenue

3.4 Global Cancer Targeted Drug Market Concentration Ratio

3.4.1 Global Cancer Targeted Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Targeted Drug Revenue in 2024

3.5 Global Key Players of Cancer Targeted Drug Head office and Area Served

3.6 Global Key Players of Cancer Targeted Drug, Product and Application

3.7 Global Key Players of Cancer Targeted Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Targeted Drug Breakdown Data by Type

4.1 Global Cancer Targeted Drug Historic Market Size by Type (2020-2025)

4.2 Global Cancer Targeted Drug Forecasted Market Size by Type (2026-2031)

5 Cancer Targeted Drug Breakdown Data by Application

5.1 Global Cancer Targeted Drug Historic Market Size by Application (2020-2025)

5.2 Global Cancer Targeted Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cancer Targeted Drug Market Size (2020-2031)

6.2 North America Cancer Targeted Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cancer Targeted Drug Market Size by Country (2020-2025)

6.4 North America Cancer Targeted Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Targeted Drug Market Size (2020-2031)

7.2 Europe Cancer Targeted Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cancer Targeted Drug Market Size by Country (2020-2025)

7.4 Europe Cancer Targeted Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Targeted Drug Market Size (2020-2031)

8.2 Asia-Pacific Cancer Targeted Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cancer Targeted Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Cancer Targeted Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Targeted Drug Market Size (2020-2031)

9.2 Latin America Cancer Targeted Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cancer Targeted Drug Market Size by Country (2020-2025)

9.4 Latin America Cancer Targeted Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Targeted Drug Market Size (2020-2031)

10.2 Middle East & Africa Cancer Targeted Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cancer Targeted Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Cancer Targeted Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Cancer Targeted Drug Introduction

11.1.4 Bayer Revenue in Cancer Targeted Drug Business (2020-2025)

11.1.5 Bayer Recent Development

11.2 Eisai

11.2.1 Eisai Company Details

11.2.2 Eisai Business Overview

11.2.3 Eisai Cancer Targeted Drug Introduction

11.2.4 Eisai Revenue in Cancer Targeted Drug Business (2020-2025)

11.2.5 Eisai Recent Development

11.3 Zelgen

11.3.1 Zelgen Company Details

11.3.2 Zelgen Business Overview

11.3.3 Zelgen Cancer Targeted Drug Introduction

11.3.4 Zelgen Revenue in Cancer Targeted Drug Business (2020-2025)

11.3.5 Zelgen Recent Development

11.4 Cipla

11.4.1 Cipla Company Details

11.4.2 Cipla Business Overview

11.4.3 Cipla Cancer Targeted Drug Introduction

11.4.4 Cipla Revenue in Cancer Targeted Drug Business (2020-2025)

11.4.5 Cipla Recent Development

11.5 Natco Pharma

11.5.1 Natco Pharma Company Details

11.5.2 Natco Pharma Business Overview

11.5.3 Natco Pharma Cancer Targeted Drug Introduction

11.5.4 Natco Pharma Revenue in Cancer Targeted Drug Business (2020-2025)

11.5.5 Natco Pharma Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Cancer Targeted Drug Introduction

11.6.4 AstraZeneca Revenue in Cancer Targeted Drug Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Cancer Targeted Drug Introduction

11.7.4 Novartis Revenue in Cancer Targeted Drug Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 Roche

11.8.1 Roche Company Details

11.8.2 Roche Business Overview

11.8.3 Roche Cancer Targeted Drug Introduction

11.8.4 Roche Revenue in Cancer Targeted Drug Business (2020-2025)

11.8.5 Roche Recent Development

11.9 Bristol-Myers Squibb

11.9.1 Bristol-Myers Squibb Company Details

11.9.2 Bristol-Myers Squibb Business Overview

11.9.3 Bristol-Myers Squibb Cancer Targeted Drug Introduction

11.9.4 Bristol-Myers Squibb Revenue in Cancer Targeted Drug Business (2020-2025)

11.9.5 Bristol-Myers Squibb Recent Development

11.10 Pfizer

11.10.1 Pfizer Company Details

11.10.2 Pfizer Business Overview

11.10.3 Pfizer Cancer Targeted Drug Introduction

11.10.4 Pfizer Revenue in Cancer Targeted Drug Business (2020-2025)

11.10.5 Pfizer Recent Development

11.11 BEACON Pharma

11.11.1 BEACON Pharma Company Details

11.11.2 BEACON Pharma Business Overview

11.11.3 BEACON Pharma Cancer Targeted Drug Introduction

11.11.4 BEACON Pharma Revenue in Cancer Targeted Drug Business (2020-2025)

11.11.5 BEACON Pharma Recent Development

11.12 Jiangxi Shanxiang

11.12.1 Jiangxi Shanxiang Company Details

11.12.2 Jiangxi Shanxiang Business Overview

11.12.3 Jiangxi Shanxiang Cancer Targeted Drug Introduction

11.12.4 Jiangxi Shanxiang Revenue in Cancer Targeted Drug Business (2020-2025)

11.12.5 Jiangxi Shanxiang Recent Development

11.13 Yao Pharma

11.13.1 Yao Pharma Company Details

11.13.2 Yao Pharma Business Overview

11.13.3 Yao Pharma Cancer Targeted Drug Introduction

11.13.4 Yao Pharma Revenue in Cancer Targeted Drug Business (2020-2025)

11.13.5 Yao Pharma Recent Development

11.14 CSPC

11.14.1 CSPC Company Details

11.14.2 CSPC Business Overview

11.14.3 CSPC Cancer Targeted Drug Introduction

11.14.4 CSPC Revenue in Cancer Targeted Drug Business (2020-2025)

11.14.5 CSPC Recent Development

11.15 CHIATAI Tianqing

11.15.1 CHIATAI Tianqing Company Details

11.15.2 CHIATAI Tianqing Business Overview

11.15.3 CHIATAI Tianqing Cancer Targeted Drug Introduction

11.15.4 CHIATAI Tianqing Revenue in Cancer Targeted Drug Business (2020-2025)

11.15.5 CHIATAI Tianqing Recent Development

11.16 Simcere

11.16.1 Simcere Company Details

11.16.2 Simcere Business Overview

11.16.3 Simcere Cancer Targeted Drug Introduction

11.16.4 Simcere Revenue in Cancer Targeted Drug Business (2020-2025)

11.16.5 Simcere Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bayer

Eisai Co Ltd

Zelgen

Cipla Ltd

Natco Pharma

Astrazeneca plc

Novartis

Roche

Bristol–Myers Squibb

Pfizer Inc

Beacon Pharma

Jiangxi Shanxiang

Yao Pharma

CSPC

Chiatai Tianqing

Simcere

List of Tables

Table 1. Global Cancer Targeted Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Sorafenib

Table 3. Key Players of Lenvatinib

Table 4. Key Players of Regorafenib

Table 5. Key Players of Osimertinib

Table 6. Key Players of Anlotinib

Table 7. Key Players of Alectinib

Table 8. Key Players of Other

Table 9. Global Cancer Targeted Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Cancer Targeted Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Cancer Targeted Drug Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Cancer Targeted Drug Market Share by Region (2020-2025)

Table 13. Global Cancer Targeted Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Cancer Targeted Drug Market Share by Region (2026-2031)

Table 15. Cancer Targeted Drug Market Trends

Table 16. Cancer Targeted Drug Market Drivers

Table 17. Cancer Targeted Drug Market Challenges

Table 18. Cancer Targeted Drug Market Restraints

Table 19. Global Cancer Targeted Drug Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Cancer Targeted Drug Market Share by Players (2020-2025)

Table 21. Global Top Cancer Targeted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Targeted Drug as of 2024)

Table 22. Ranking of Global Top Cancer Targeted Drug Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Cancer Targeted Drug Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Cancer Targeted Drug, Headquarters and Area Served

Table 25. Global Key Players of Cancer Targeted Drug, Product and Application

Table 26. Global Key Players of Cancer Targeted Drug, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Cancer Targeted Drug Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Cancer Targeted Drug Revenue Market Share by Type (2020-2025)

Table 30. Global Cancer Targeted Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Cancer Targeted Drug Revenue Market Share by Type (2026-2031)

Table 32. Global Cancer Targeted Drug Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Cancer Targeted Drug Revenue Market Share by Application (2020-2025)

Table 34. Global Cancer Targeted Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Cancer Targeted Drug Revenue Market Share by Application (2026-2031)

Table 36. North America Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Cancer Targeted Drug Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Cancer Targeted Drug Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Cancer Targeted Drug Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Cancer Targeted Drug Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Cancer Targeted Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Cancer Targeted Drug Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Cancer Targeted Drug Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Cancer Targeted Drug Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Cancer Targeted Drug Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Cancer Targeted Drug Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Cancer Targeted Drug Market Size by Country (2026-2031) & (US$ Million)

Table 51. Bayer Company Details

Table 52. Bayer Business Overview

Table 53. Bayer Cancer Targeted Drug Product

Table 54. Bayer Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 55. Bayer Recent Development

Table 56. Eisai Company Details

Table 57. Eisai Business Overview

Table 58. Eisai Cancer Targeted Drug Product

Table 59. Eisai Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 60. Eisai Recent Development

Table 61. Zelgen Company Details

Table 62. Zelgen Business Overview

Table 63. Zelgen Cancer Targeted Drug Product

Table 64. Zelgen Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 65. Zelgen Recent Development

Table 66. Cipla Company Details

Table 67. Cipla Business Overview

Table 68. Cipla Cancer Targeted Drug Product

Table 69. Cipla Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 70. Cipla Recent Development

Table 71. Natco Pharma Company Details

Table 72. Natco Pharma Business Overview

Table 73. Natco Pharma Cancer Targeted Drug Product

Table 74. Natco Pharma Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 75. Natco Pharma Recent Development

Table 76. AstraZeneca Company Details

Table 77. AstraZeneca Business Overview

Table 78. AstraZeneca Cancer Targeted Drug Product

Table 79. AstraZeneca Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 80. AstraZeneca Recent Development

Table 81. Novartis Company Details

Table 82. Novartis Business Overview

Table 83. Novartis Cancer Targeted Drug Product

Table 84. Novartis Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 85. Novartis Recent Development

Table 86. Roche Company Details

Table 87. Roche Business Overview

Table 88. Roche Cancer Targeted Drug Product

Table 89. Roche Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 90. Roche Recent Development

Table 91. Bristol-Myers Squibb Company Details

Table 92. Bristol-Myers Squibb Business Overview

Table 93. Bristol-Myers Squibb Cancer Targeted Drug Product

Table 94. Bristol-Myers Squibb Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 95. Bristol-Myers Squibb Recent Development

Table 96. Pfizer Company Details

Table 97. Pfizer Business Overview

Table 98. Pfizer Cancer Targeted Drug Product

Table 99. Pfizer Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 100. Pfizer Recent Development

Table 101. BEACON Pharma Company Details

Table 102. BEACON Pharma Business Overview

Table 103. BEACON Pharma Cancer Targeted Drug Product

Table 104. BEACON Pharma Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 105. BEACON Pharma Recent Development

Table 106. Jiangxi Shanxiang Company Details

Table 107. Jiangxi Shanxiang Business Overview

Table 108. Jiangxi Shanxiang Cancer Targeted Drug Product

Table 109. Jiangxi Shanxiang Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 110. Jiangxi Shanxiang Recent Development

Table 111. Yao Pharma Company Details

Table 112. Yao Pharma Business Overview

Table 113. Yao Pharma Cancer Targeted Drug Product

Table 114. Yao Pharma Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 115. Yao Pharma Recent Development

Table 116. CSPC Company Details

Table 117. CSPC Business Overview

Table 118. CSPC Cancer Targeted Drug Product

Table 119. CSPC Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 120. CSPC Recent Development

Table 121. CHIATAI Tianqing Company Details

Table 122. CHIATAI Tianqing Business Overview

Table 123. CHIATAI Tianqing Cancer Targeted Drug Product

Table 124. CHIATAI Tianqing Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 125. CHIATAI Tianqing Recent Development

Table 126. Simcere Company Details

Table 127. Simcere Business Overview

Table 128. Simcere Cancer Targeted Drug Product

Table 129. Simcere Revenue in Cancer Targeted Drug Business (2020-2025) & (US$ Million)

Table 130. Simcere Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. Authors List of This Report

List of Figures

Figure 1. Cancer Targeted Drug Picture

Figure 2. Global Cancer Targeted Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cancer Targeted Drug Market Share by Type: 2024 VS 2031

Figure 4. Sorafenib Features

Figure 5. Lenvatinib Features

Figure 6. Regorafenib Features

Figure 7. Osimertinib Features

Figure 8. Anlotinib Features

Figure 9. Alectinib Features

Figure 10. Other Features

Figure 11. Global Cancer Targeted Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Cancer Targeted Drug Market Share by Application: 2024 VS 2031

Figure 13. Hospital Case Studies

Figure 14. Retail Pharmacy Case Studies

Figure 15. Other Case Studies

Figure 16. Cancer Targeted Drug Report Years Considered

Figure 17. Global Cancer Targeted Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Cancer Targeted Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Cancer Targeted Drug Market Share by Region: 2024 VS 2031

Figure 20. Global Cancer Targeted Drug Market Share by Players in 2024

Figure 21. Global Top Cancer Targeted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Targeted Drug as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Cancer Targeted Drug Revenue in 2024

Figure 23. North America Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Cancer Targeted Drug Market Share by Country (2020-2031)

Figure 25. United States Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Cancer Targeted Drug Market Share by Country (2020-2031)

Figure 29. Germany Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Cancer Targeted Drug Market Share by Region (2020-2031)

Figure 37. China Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Cancer Targeted Drug Market Share by Country (2020-2031)

Figure 45. Mexico Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Cancer Targeted Drug Market Share by Country (2020-2031)

Figure 49. Turkey Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Cancer Targeted Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Bayer Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 53. Eisai Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 54. Zelgen Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 55. Cipla Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 56. Natco Pharma Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 57. AstraZeneca Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 58. Novartis Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 59. Roche Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 61. Pfizer Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 62. BEACON Pharma Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 63. Jiangxi Shanxiang Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 64. Yao Pharma Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 65. CSPC Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 66. CHIATAI Tianqing Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 67. Simcere Revenue Growth Rate in Cancer Targeted Drug Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions